dextroamphetamine has been researched along with Disorders of Excessive Somnolence in 7 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
Excerpt | Relevance | Reference |
---|---|---|
"The manifestations of daytime somnolence and abnormal sleep behavior have been described in SCA type 3 (SCA3) and SCA type 6 (SCA6), but as yet have not been described in SCA type 1 (SCA1)." | 1.36 | Excessive daytime somnolence in spinocerebellar ataxia type 1. ( Cunnington, D; Dang, D, 2010) |
"The daytime somnolence was confirmed objectively by polygraphic monitoring seven weeks to 4 1/2 months after the onset of clinical symptoms." | 1.27 | Mononucleosis and chronic daytime sleepiness. A long-term follow-up study. ( Guilleminault, C; Mondini, S, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dang, D | 1 |
Cunnington, D | 1 |
Elkay, M | 1 |
Bergin, AM | 1 |
Kothare, SV | 1 |
Wesensten, NJ | 1 |
Killgore, WD | 2 |
Balkin, TJ | 2 |
Ismail, D | 1 |
O'Connell, MA | 1 |
Zacharin, MR | 1 |
McBride, SA | 1 |
Killgore, DB | 1 |
Guilleminault, C | 1 |
Mondini, S | 1 |
1 review available for dextroamphetamine and Disorders of Excessive Somnolence
Article | Year |
---|---|
Managing excessive daytime sleepiness in adults.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Dextroamphetamine; Disorders of Exce | 2004 |
1 trial available for dextroamphetamine and Disorders of Excessive Somnolence
Article | Year |
---|---|
The effects of caffeine, dextroamphetamine, and modafinil on humor appreciation during sleep deprivation.
Topics: Adolescent; Adult; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cognition; Dex | 2006 |
5 other studies available for dextroamphetamine and Disorders of Excessive Somnolence
Article | Year |
---|---|
Excessive daytime somnolence in spinocerebellar ataxia type 1.
Topics: Activities of Daily Living; Amantadine; Ataxin-1; Ataxins; Brain Stem; Cerebellum; Citalopram; Dextr | 2010 |
Clinical reasoning: a teenage girl with excessive daytime sleepiness, "fainting spells," and dream mentations.
Topics: Adolescent; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Disorders of Excessiv | 2010 |
Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
Topics: Adult; Arousal; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cognition; Dextro | 2005 |
Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
Topics: Adolescent; Central Nervous System Stimulants; Child; Child, Preschool; Craniopharyngioma; Dextroamp | 2006 |
Mononucleosis and chronic daytime sleepiness. A long-term follow-up study.
Topics: Adolescent; Adult; Chronic Disease; Circadian Rhythm; Dextroamphetamine; Disorders of Excessive Somn | 1986 |